For instance, antibodies targeting two B7/CD28 family checkpoint proteins, CTLA-4 and PD-1, have recently been approved for the treatment of advanced melanoma [14–16] and B7-1 expression has been reported to be increased in pancreatic cancer [17, 18]. Here, CD80 is linked to familial pancreatic carcinoma.